William R. Huckle, Editor
Track all things NAVBO
Postponed until Summer 2021
September 9-12, 2020
Abstract deadline extended to
July 17, 2020
Vascular Biology 2020
An exciting virtual event
October 26-29, 2020
Vascular Biology Publications Alert Now Available by Subscription
The NAVBO Vascular Biology Publications Alert will now be available to non-members for a $55 a year subscription. If you would like to receive this alert, but are not a member, please contact Danielle at firstname.lastname@example.org.
Partner Network Advantage on the NAVBO Job Board
Why post your job on NAVBO's career center rather than going directly to the larger job networks?
Pricing on the mass job boards can vary, but to get a job noticed you typically have to sponsor it for $5 - $10 per day, which can add up quickly especially since you also pay for each click the job gets. When you add it all together, you could be spending up to $45 per day on your job posting. But, when posting a job on NAVBO's career center, you simply pay a flat fee! The Premium package includes our Exclusive Extended Partner Network - which means the jobs are broadcast to sites like ZipRecruiter and Jobs2Careers and more for a flat fee.
With special member pricing, you can post a job for as low as $300 with this Partner Network. You never pay for each click, just the flat fee on the NAVBO career center. In addition, the Premium package includes a 60-day job posting making it a great value. The Premium packages also offer features like having your company's logo featured on the career center homepage, having your job appear first in search results, and more.
Please review our policy
as time permits so you have a complete understanding of the data we have, why we have it, and how we use it.
Part of the updates relate directly to the European Union's new General Data Protection Regulation (GDPR) that went into place May 25. The GDPR seeks to improve the transparency of data usage and give end users more control over their own data. We believe these changes are important and will be compliant with the GDPR regulations.
Contact NAVBO if you have any questions or to
change your communication preferences.
Please note, you can unsubscribe to this newsletter at anytime by clicking on the SafeUnsubscribe in the footer.
Message from Our New President
Growth opportunities are the bright side of these challenging times
2020 has been an exceptionally challenging year. After having caused enormous damage,
the COVID-19 pandemic has shown no signs of disappearing. What were the major obstacles to acting in a timely fashion to prevent this devastating health threat from spreading? One appears to be that the initial responses of many governments did not reflect scientific predictions that immediate aggressive measures might save many lives. The United States is now also facing the need to address the complex issues associated with the consequences of racism. It is necessary that we, as a scientific community, think about what we can do to help deal with these dual disasters. While we are not immune to the negative consequences of these challenges, they do provide opportunities for us to think about our roles.
Dr. Aikawa, President of NAVBO, has more to share with you about diversity, new technologies and the importance of science. Read more.
Join us Today!
Sara Nunes de Vasconcelos of the Toronto General Research Institute will present a webinar titled,
Therapeutic Vascularization for Tissue Regeneration, today at 1:00pmET. Plan to join us!
Tweet this! Join our webinar on Therapeutic Vascularization for Tissue Regeneration. https://www.navbo.org/events/webinars/928-web072020
Our August 13 webinar on
, will be very special! Organized by NAVBO Member, Kazuhide Okuda of the Peter MacCallum Cancer Centre, this session will feature Natasha Harvey of the University of South Australia and Jonathan Astin of the University of Auckland. The session will be held on Thursday evening at 8pm so that
our colleagues in Asia and Australia can tune in live!
NAVBO Webinars are free to current NAVBO Members. Non-members can attend for $25 per webinar. Hint:
And don't forget you can watch recorded webinars as well - go to
|Seeking Nominations for NAVBO Awards
Submit a Nomination for the NAVBO Meritorious Awards
The NAVBO Meritorious Awards Committee is currently seeking nominations for our two most prestigious awards - the
Earl P. Benditt Award which recognizes an individual who has made an outstanding discovery or developed a concept that has been seminal to our understanding of vascular biology or pathology; and the Judah Folkman Award in Vascular Biology, for an individual who is mid-
career (between 3 and 15 years of their first
faculty appointment) and has made a significant impact on the field of vascular biology through his/her original research accomplishments.
Very excited to be joined by:
The Microcirculatory Society
American Society for Investigative Pathology
What's New - or should I say who's new, at Vascular Biology 2020?
Of course being virtual is definitely something new, but we have a lot of new speakers at this year's meeting that we want to introduce to you:
Katerina Akassoglou, UCSF/Gladstone Institutes
Pilar Alcaide, Tufts Medical Center
Melissa Brown, Northwestern University Feinberg School of Medicine
Mark Caulfield, Queen Mary University of London
Sangeeta Chavan, The Feinstein Institute for Medical Research
Jichao Chen, MD Anderson Cancer Center
Claire Doerschuk, University of North Carolina at Chapel Hill
Britta Engelhardt, University of Bern
Zsuzsanna Fabry, University of Wisconsin
Dai Fukumura, Massachusetts General Hospital, Harvard Medical School
Jean-Philippe Girard, CNRS-University of Toulouse
Joanna Kalucka, Aarhus University
Denuja Karunakaran, University of Queensland
Minsoo Kim, University of Rochester Medical Center
Jonathan Kipnis, University of Virginia
Calvin Kuo, Stanford University
Lars Maegdefessel, Technical University Munich
Catherine Makarewich, Cincinnati Children's Hospital
Louise McCullough, University of Texas Health Science Center at Houston
Stryder Meadows, Tulane University
Maiken Nedergaard, University of Rochester Medical Center
Amy Nelson, University of Southern California
Mauro Perretti, Queen Mary University of London
Michael Potente, Max Planck Institute for Heart and Lung Research
Casey Romanoski, University of Arizona
David Sullivan, Northwestern University Feinberg School of Medicine
Elizabeth Tarling, University of California, Los Angeles
Jaap van Buul, Sanquin Research and Landsteiner Laboratory
Plans are still underway for the program within the virtual format. According to our survey, most members prefer that we stick to the four-day schedule, so the meeting dates are October 26-29, 2020.
We are including some exciting opportunities - Poster Discussions, Evening Discussions (perfect for our friends in Asia and Australia), Networking Discussions and more.
We recognize that you may not be able to register at this time, but please do submit an abstract! The deadline is August 3, 2020.
Tweet this! Register for Vascular Biology 2020. https://www.navbo.org/events/vb2020
Special Opportunity for Trainee Members!!
Emerging Scientists Series - Add Your Profile!!
Take advantage of this opportunity to showcase your work for would-be employers. Join Cody on our web site!
We have heard from a number of people that both graduation ceremonies and thesis presentations have been cancelled and/or reformatted for remote participation. Coupled with the temporary halt in in-person conferences, this situation may be making it more challenging for trainees to network, promote their science, and search for their next position. To address this, NAVBO will offer online opportunities for our trainee members.
The new Emerging Scientists Series will offer trainees the opportunity to showcase their thesis research in short research highlight talks. This new resource will serve as a place for trainees to share their work with employers that are hiring and searching for a new recruit with vascular biology research experience. Postdocs - looking for your first faculty position? You can use this service as well.
If you are a trainee that has just defended your thesis, or a postdoc seeking your first faculty position and are interested in this opportunity, please contact email@example.com
Harvard, MIT, student advocates contest new Homeland Security rules on international study in US
Harvard and MIT have
challenged the Trump administration
in court, opposing the recent directive from ICE that would force foreign students to return home if courses this fall are available to them only online. Advocates note that the new policy in essence requires students to choose between their health and their visa standing; similarly, institutions may feel pressured to open more fully than is consistent with sound public health practices. Many universities are planning a hybrid model, with some in-person instruction but mostly remote classes. The new rules mark a retreat from exceptions granted by ICE in March, when F-1 visa holders were relieved of having to attend most classes in person in view of the coronavirus pandemic. University and
leaders have been quick to issue statements of support for their international students and their dismay at the tightened directives.
Development in Cardiovascular Disease - July 15 at 1:00pmET
Webinars included are:
Please review their recorded webinars prior to the live discussion on June 15
The session will be moderated by Nicholas Chavkin, University of Virginia
"Join the Club" on July 16 at 1:00pm ET
Join presenter William Hughes, Medical College of Wisconsin, and Moderator, Mabruka Alfaidi, Louisiana State University, as we discuss:
Mitochondrial Fission Mediates Endothelial Inflammation
Steven J. Forrester, Kyle J. Preston, Hannah A. Cooper, Michael J. Boyer, Kathleen M. Escoto, Anthony J. Poltronetti, Katherine J. Elliott, Ryohei Kuroda, Masashi Miyao, Hiromi Sesaki, Tomoko Akiyama, Yayoi Kimura, Victor Rizzo, Rosario Scalia, Satoru Eguchi
Have you read a paper (published within the last three months) that you think covers a topical discussion point for NAVBO members? Are you interested in presenting a paper? Would you like a paper you authored presented and discussed in our Journal Club? If yes to any of these questions, please send your recommendations to firstname.lastname@example.org
Welcome to our New Members:
Wafa Altalhi, MGH
Coelho-Santos, Seattle Children's Research Institute
Rolando Cuevas, University of Pittsburgh
Cristiane de Leis, University of Miami
Gabrielle Fredman, Brigham and Women's Hospital Harvard Medical School
Marie Guerraty, University of Pennsylvania
Shinobu Matsuura, Boston University School of Medicine
Cameron McCarthy, University of Toledo
Seattle Children's Hospital/University of Washington
|Recent Publications by NAVBO Members
Localization of TRPA1 Channels and Characterization of TRPA1 Mediated Responses in Dural and Pial Arteries in Vivo After Intracarotid Infusion of Na 2 S
Background: The Transient Receptor Potential Ankyrin 1 (TRPA1) channel might play a role in migraine. However, different mechanisms for this have been suggested. The purpose of our study was to investigate the localization and significance of TRPA1 channels in rat pial and dural arteries. Read more
Inflammation Profiling of Critically Ill Coronavirus Disease 2019 Patients
Critical Care Explorations
Coronavirus disease 2019 is caused by severe acute respiratory syndrome-coronavirus-2 infection to which there is no community immunity. Patients admitted to ICUs have high mortality, with only supportive therapies available. Read more
Prostaglandin E2 Breaks Down Pericyte-Endothelial Cell Interaction via EP1 and EP4-dependent Downregulation of Pericyte N-cadherin, connexin-43, and R-Ras
A close association between pericytes and endothelial cells (ECs) is crucial to the stability and function of capillary blood vessels and microvessels. The loss or dysfunction of pericytes results in significant disruption of these blood vessels as observed in pathological conditions, including cancer, diabetes, stroke, and Alzheimer's disease.
AAMC and CITI collaborate to share collective guidance on returning to research
The Association of American Medical Schools has joined forces with online training platform CITI and several leading academic institutions to produce COVID-19: Back to Campus (Fall 2020), preparing researchers and staff for a fall return. The program aims to help investigators navigate emerging regulatory guidance from multiple agencies including the CDC and NIH. Recommendations for best practices are included from Vanderbilt, Yale, Northwestern and other institutions. Modules cover a variety of topics from prevention strategies and human subjects research, to supporting employee mental health and well-being. Access to this course is free through 1 October 2020.
Breakthrough in mitochondrial genome editing
Beverly Mok of the Broad Institute and colleagues report in Nature the development of molecular tools that enable editing of the mitochondrial genome. The technique makes use of a bacterial intertoxin, DddA, that catalyzes the deamination of cytidines within dsDNA. By coupling this novel property with elements of the CRISPR and TALEN gene editing approaches, the team was able to modify mitochondrial sequences in a manner that predictably modulated respiration rates and oxidative phosphorylation in cultured human cells. This work raises the hope that treatment of mitochondrial disorders with known genetic bases may become more tractable.
American Red Cross adapts its blood collection and distribution procedures to the COVID-19 world
In mid-June, the American Red Cross began testing all donated blood, platelet and plasma for SARS-CoV2 antibodies, providing donors awareness of their potential exposure to the novel coronavirus. The FDA-authorized test for anti-CoV2 antibodies thus becomes part of the battery of assays routinely performed to screen donated blood products for evidence of infectious agents. Separately and in partnership with the FDA, the Red Cross has developed a process to identify and qualify individuals who have recovered from COVID-19 and to collect convalescent plasma. The organization expects this work to speed access by clinicians to this experimental treatment for the most seriously ill patients.
Frontiers in Cardiovascular Medicine
Special Research Topics
Putting Engineering Back In Vascular Tissue Engineering To Advance Basic Science and Clinical Applications
Topic Editors: Jessica Wagenseil (Washington University in St. Louis) and W. Lee Murfee (University of Florida).
This topic is sponsored by NAVBO
Vascular tissue engineering (VTE) can be characterized as the creation of replacement vessels. Over the past 30 years, approaches have incorporated different combinations of extracellular matrix scaffolds, cells and biological active chemical cues. Challenged by the goal to recapitulate the complexity of big or small vessels, the clinical use of in vitro tissue engineered vessel replacements is still limited. With research more often focusing on reductionist materials science or cell biology characterization of vessel-like constructs, an opportunity has emerged to re-apply engineering approaches to guide the next step in VTE.
Submit your manuscript by October 17, 2020
What do we know about COVID-19 implications for cardiovascular disease?
The coronavirus epidemic causes major cardiovascular complications. Underlying mechanisms, however, remain incompletely understood. Frontiers in Cardiovascular Medicine invite you to submit your article on this topic. We consider all types of manuscripts: fundamental basic science reports, translational or clinical studies, review articles and methodology papers.
Submit your manuscript by August 28, 2020